News & Articles

Proprietary enzymatic synthesis technology produces high-quality sequences up to 3,000 nucleotides long

Single cell-sequencing technology will be used by Labcorp to support clinical trials and evaluate potential applications in clinical diagnostics and companion diagnostics development

Keep up with the latest trends and hot topics in our life sciences community and find out what not to miss in March

New publication finds highly accurate molecular diagnoses of facioscapulohumeral muscular dystrophy (FSHD), a hereditary muscle disease

Difficult decision as 56 entries whittled down to three

NGS DreamPrep™ promises unprecedented speed and accuracy for automated library preparation

Relive the biggest stories of the month and find out what’s been making waves in the SelectScience life sciences community since the turn of the year

Forensics Europe Expo will be taking place on 5-6 March 2019, Olympia, London

Genomic analysis tools SIRIUS and MERCURY to be implemented into the Google Cloud Platform

In this SelectScience special feature, learn about the latest in next-generation sequencing (NGS) technologies and techniques

Contract researchers and cancer biologists, Robert B. Harris, Ph.D., Thomas Reynolds, and Gregory A. Meyers, owners and founders of NEXT Molecular Analytics, have joined the DNA sequencing revolution. To keep up their research momentum, they consider a next big step — automation

Findings presented at ASHG 2018 annual meeting shed light on the biology behind type-2 asthma

Findings reported at ASHG 2018 annual meeting describe new associations between environmental factors and pharmacogenes

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications

The new fund will finance high-risk, high-reward ideas to drive innovation

Missed our fascinating NGS webinar? Catch up on demand and read the Q&A highlights below

Novel DNA repair enzyme gives insight into chemotherapy resistant tumors and neurodegenerative disorders

Bruker’s TargetScreener HR 3.1 is proposed to enhance productivity and minimize false positives and negatives

Affordable, High-Resolution Imaging System Designed for Busy Laboratories